… Operating and Financial Results Axiomer™ ADAR-mediated RNAediting pipeline advancing across liver and CNS programs, … In March, ProQR participated in the RNAEditingGordonResearchConference in Lucca, Italy, presenting …
Initial pipeline programs with liver delivery to address Cholestatic Diseases targeting NTCP and Cardiovascular Disease targeting B4GALT1
Development of Axiomer® RNA base editing technology platform continues across multiple therapeutic areas
Stre